You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: September 25, 2023

Patent: 8,277,822

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,277,822
Title:Botulinum toxin treatment
Abstract: A liquid or semi-solid formulation of botulinum toxin for the preparation of a medicament intended to treat a disorder characterized by bladder spasms (e.g. urinary incontinence due to unstable bladder or unstable detrusor sphincter, voiding complications due to detrusor overactivity or unstable detrusor sphincter, urinary retention secondary to spastic sphincter or hypertrophied bladder neck and neurogenic bladder dysfunction secondary to Parkinson\'s disease, spinal cord injury, stroke or multiple sclerosis or characterized by a spasm reflex), wherein said medicament is for administration by infusion into the bladder or by other methods that do not involve injection into the bladder wall.
Inventor(s): Dott; Chris (Berkshire, GB), Batchelor; John (Berkshire, GB), Bernard D\'Arbigny; Pierre (Courbevoie, FR), Cherif-Cheikh; Roland (Barcelona, ES)
Assignee: Ipsen Biopharm Limited (Wrexham, GB)
Application Number:12/155,104
Patent Claims:see list of patent claims

Details for Patent 8,277,822

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Solstice Neurosciences, Llc MYOBLOC rimabotulinumtoxinb Injection 103846 12/08/2000 ⤷  Try a Trial 2023-12-04
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.